91¿ì²¥ Launches Rx Intelligence Technology to Curb Opioid Epidemic

DETECTING QUESTIONABLE DRUG USAGE EARLY & CUTTING UNNECESSARY COSTS WITH ANALYTICS

September 25, 2012 – Chicago, IL – New technology has just been released that provides early detection of questionable drug usage behavior to reduce payer costs and improve employee health outcomes. 91¿ì²¥â€™ Rx Intelligence technology targets the workers’ compensation industry’s opioid epidemic. With Americans consuming 80 percent of the world’s opioid supply, it’s a scourge that’s significantly impacting our nation and our injured workers.

Claims with long-acting opioid prescriptions are costing 9.3 times more than claims without, according to the August edition of the Journal of Occupational & Environmental Medicine, the latest in a string of industry studies. When long-acting opioid painkillers are prescribed, workers’ compensation claims are nearly four times more likely to turn into catastrophic claims with costs tallying more than $100,000, the study also found.

The company’s launch of Rx Intelligence technology helps ensure injured workers receive appropriate meds, while curtailing narcotic overprescribing and overuse – narcotics represent roughly 25% of all workers’ comp drug costs. 91¿ì²¥ is using analytics to monitor an injured worker’s prescription drug activity and alert users to “at-risk†cases so that early intervention can take place to prevent costly drug misuse or abuse.  Key functionality includes:

  • Complete medical picture, in addition to prescription fill data
  • Urine drug screening insight
  • Prescription activity for multiple providers
  • Identification of escalating or weaning patterns
  • Utilization of any formulary (e.g. payer-specific, state-specific, blended)
  • Tracking of any prescription drug, not just opioids

â€In any pharmacy review, if a person is taking an opioid, they are likely taking many other drugs that could be problematic,†says Anne Kirby, 91¿ì²¥â€™s Chief Compliance Officer and Vice President of Care Management. “That’s why we don’t just deal with opioids in a vacuum, as other drugs impact how opioids are used and influence their effect.â€

Enlisting Rx analytics as one integral tool in the fight against prescription drug misuse and abuse is featured in 91¿ì²¥’s new white paper, Fighting the Rx Epidemic: A Prescription for Workers’ Comp. To read what the top minds in workers’ comp, government, healthcare and academia are recommending as the multi-pronged fix, download a copy.

About 91¿ì²¥
91¿ì²¥ is a national medical-financial solutions firm that provides medical care management and medical cost containment services to the workers’ compensation, auto, liability and group health markets.